CGCT vs ACIC vs HCI vs UPC

For growth investors, HCI Group, Inc.

(HCI) is the stronger pick with 20. 2% revenue growth year-over-year, versus -22. 4% for Universe Pharmaceuticals Inc. (UPC). American Coastal Insurance Corporation (ACIC) offers the better valuation at 4. 9x trailing P/E (10. 9x forward), making it the more compelling value choice. Analysts rate HCI Group, Inc. (HCI) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, American Coastal Insurance Corporation (ACIC) is the cheapest at 4.

9x versus Cartesian Growth Corporation III at 61. 4x. On forward P/E, HCI Group, Inc. is actually cheaper at 9. 3x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, American Coastal Insurance Corporation (ACIC) delivered a total return of +98.

7%, compared to -100. 0% for Universe Pharmaceuticals Inc. (UPC). Over 10 years, the gap is even starker: HCI returned +491. 7% versus UPC's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), American Coastal Insurance Corporation (ACIC) is the lower-risk stock at 0.

10β versus Universe Pharmaceuticals Inc. 's 0. 94β — meaning UPC is approximately 808% more volatile than ACIC relative to the S&P 500. On balance sheet safety, HCI Group, Inc. (HCI) carries a lower debt/equity ratio of 6% versus 48% for American Coastal Insurance Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), HCI Group, Inc.

(HCI) is pulling ahead at 20. 2% versus -22. 4% for Universe Pharmaceuticals Inc. (UPC). On earnings-per-share growth, the picture is similar: Cartesian Growth Corporation III grew EPS 589. 2% year-over-year, compared to 26. 5% for Universe Pharmaceuticals Inc.. Over a 3-year CAGR, HCI leads at 22. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

HCI Group, Inc.

(HCI) is the more profitable company, earning 33. 2% net margin versus -20. 6% for Universe Pharmaceuticals Inc. — meaning it keeps 33. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HCI leads at 47. 7% versus -16. 3% for UPC. At the gross margin level — before operating expenses — ACIC leads at 86. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, HCI Group, Inc.

(HCI) trades at 9. 3x forward P/E versus 10. 9x for American Coastal Insurance Corporation — 1. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HCI: -21. 2% to $126. 50.

In this comparison, HCI (0.

9% yield) pays a dividend. CGCT, ACIC, UPC do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, HCI Group, Inc.

(HCI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 36), 0. 9% yield, +491. 7% 10Y return). Both have compounded well over 10 years (HCI: +491. 7%, UPC: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (CGCT (Financial Services) and ACIC (Financial Services) and HCI (Financial Services) and UPC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CGCT is a small-cap quality compounder stock; ACIC is a small-cap deep-value stock; HCI is a small-cap high-growth stock; UPC is a small-cap quality compounder stock. HCI pays a dividend while CGCT, ACIC, UPC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.